This COVID-19 FRONTLINE Whiteboard series will explore the role of emerging monoclonal antibody therapies and vaccines in managing the COVID-19 pandemic. Each module will focus on clinical trial data and aid clinicians in identifying patients who would benefit from therapy.
In this module, we will review the mechanism of action of monoclonal antibody therapies and vaccines for the prevention and treatment of COVID-19, and assess the efficacy and safety of these emerging therapies.
Release Date: February 2, 2021
Expiration Date: February 2, 2022